Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Squamous Cell Carcinoma of Head and Neck × camrelizumab × Clear all

Phase

Status

Sponsor Class

OTHER 13 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 2 sintilimab 1 nabiximols 1 camrelizumab 1 anlotinib 1 Platinum Compounds 1 Palonosetron 1 Olanzapine 1 Drug Therapy 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04861467 2021-04-27

Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

ChineseAMS

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡